A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Full Title

A Phase II Trial of Neoadjuvant Trastuzumab Deruxtecan for Patients with Stage II-III HER2-Amplified or HER2-Mutated Non-Small Cell Lung Cancer (HERCULES)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. James Isbell’s office at 212-639-6247.

Protocol

25-110

Phase

Phase II (phase 2)

Investigator

James M. Isbell

Co-Investigators

Jamie E. Chaft
David R. Jones
Fernando Santini

Diseases

Lung Cancer › Lung Cancer, Non-Small Cell

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07428044

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description